CY1115708T1 - Τοπικες συνθεσεις για τη διατηρηση ή την ανακτηση της ακεραιοτητας των βλεννογονων - Google Patents

Τοπικες συνθεσεις για τη διατηρηση ή την ανακτηση της ακεραιοτητας των βλεννογονων

Info

Publication number
CY1115708T1
CY1115708T1 CY20141100854T CY141100854T CY1115708T1 CY 1115708 T1 CY1115708 T1 CY 1115708T1 CY 20141100854 T CY20141100854 T CY 20141100854T CY 141100854 T CY141100854 T CY 141100854T CY 1115708 T1 CY1115708 T1 CY 1115708T1
Authority
CY
Cyprus
Prior art keywords
conservation
incorporation
muscle
recovery
local compositions
Prior art date
Application number
CY20141100854T
Other languages
English (en)
Inventor
Schiena Michele Giuseppe Di
Original Assignee
Ricerfarma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricerfarma Srl filed Critical Ricerfarma Srl
Publication of CY1115708T1 publication Critical patent/CY1115708T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Η παρούσα εφεύρεση αφορά τοπικές συνθέσεις, οι οποίες περιέχουν αλφοσκερική χολίνη, για χρήση εις τη διατήρηση και ανάκτηση της ακεραιότητας των βλεννογόνων υμένων.
CY20141100854T 2010-11-30 2014-10-16 Τοπικες συνθεσεις για τη διατηρηση ή την ανακτηση της ακεραιοτητας των βλεννογονων CY1115708T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A002218A IT1402907B1 (it) 2010-11-30 2010-11-30 Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose.
EP11805602.7A EP2646036B1 (en) 2010-11-30 2011-11-29 Topical compositions for preserving or restoring the integrity of mucosae

Publications (1)

Publication Number Publication Date
CY1115708T1 true CY1115708T1 (el) 2017-01-25

Family

ID=43742830

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100854T CY1115708T1 (el) 2010-11-30 2014-10-16 Τοπικες συνθεσεις για τη διατηρηση ή την ανακτηση της ακεραιοτητας των βλεννογονων

Country Status (23)

Country Link
US (1) US9050351B2 (el)
EP (1) EP2646036B1 (el)
JP (1) JP5847833B2 (el)
KR (1) KR101845472B1 (el)
CN (1) CN103313716B (el)
AU (1) AU2011336166B2 (el)
BR (1) BR112013013351B1 (el)
CA (1) CA2819307C (el)
CY (1) CY1115708T1 (el)
DK (1) DK2646036T3 (el)
ES (1) ES2521065T3 (el)
HK (1) HK1185008A1 (el)
HR (1) HRP20141099T1 (el)
IL (1) IL226638A (el)
IT (1) IT1402907B1 (el)
MX (1) MX337437B (el)
PL (1) PL2646036T3 (el)
PT (1) PT2646036E (el)
RS (1) RS53598B1 (el)
RU (1) RU2013125021A (el)
SI (1) SI2646036T1 (el)
WO (1) WO2012073191A1 (el)
ZA (1) ZA201303910B (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940724A (zh) * 2012-08-16 2013-02-27 江西普正制药有限公司 一种用于消炎的中药复方胶囊的制备方法
ITMI20131219A1 (it) * 2013-07-19 2015-01-20 Ricerfarma Srl Colina alfoscerato come inibitore di ialuronidasi
RU2551312C1 (ru) * 2014-04-24 2015-05-20 Людмила Владимировна Уварова Способ восстановления тканей зубочелюстной системы
KR101853347B1 (ko) * 2014-08-29 2018-04-30 주식회사유한양행 콜린 알포세레이트-함유 정제 및 이의 제조방법
ES2827426T3 (es) * 2015-03-26 2021-05-21 Dmg Italia Srl Composición oftálmica para la protección corneal
CZ28634U1 (cs) 2015-05-05 2015-09-14 Contipro Pharma A.S. Dentální přípravek na bázi hyaluronanu a oktenidin dihydrochloridu
RU2632718C2 (ru) * 2015-12-25 2017-10-09 Общество с ограниченной ответственностью "Фармамед" Спрей для орального применения, содержащий холина альфосцерат.
KR101744538B1 (ko) * 2017-03-17 2017-06-09 주식회사 대웅제약 콜린 알포세레이트를 함유하는 수성 액상 제제
IT201700048750A1 (it) * 2017-05-05 2018-11-05 Farm Procemsa S P A Composizione per il trattamento di afte e ulcere buccali
RU2684118C2 (ru) * 2017-09-27 2019-04-04 Общество с ограниченной ответственностью "Фармамед" Спрей для орального применения, содержащий холина альфосцерат
KR101864384B1 (ko) * 2017-12-11 2018-06-04 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 쥐남의 치료, 개선 또는 예방용 조성물 및 방법
WO2019208898A1 (ko) * 2018-04-24 2019-10-31 한국유나이티드제약 주식회사 콜린알포세레이트를 함유하는 액상 시럽제제
CN108452291A (zh) * 2018-07-04 2018-08-28 西南大学 用天然丝胶蛋白治疗溃疡性结肠炎的方法
BR112021024266A2 (pt) 2019-06-14 2022-01-11 Procter & Gamble Composições para tratamento bucal sem enxágue
EP3982913A1 (en) * 2019-06-14 2022-04-20 The Procter & Gamble Company Leave-on oral care compositions
MX2021015126A (es) * 2019-06-14 2022-01-24 Procter & Gamble Composiciones para el cuidado bucal para usar y no enjuagar.
IT202000004069A1 (it) * 2020-02-27 2021-08-27 Ricerfarma Srl Composizioni topiche per il mantenimento e/o ripristino dell’integrità delle mucose e dell’epidermide lesa
IT202000022042A1 (it) * 2020-09-18 2022-03-18 Ricerfarma Srl Composizioni topiche antivirali comprendenti acido ialuronico e carragenina

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1240316B (it) * 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
CH683671A5 (it) * 1992-03-30 1994-04-29 Golgi Sa Uso topico di glicerofosfolipidi deacilati.
JPH06107550A (ja) * 1992-09-29 1994-04-19 Yutaka Kurachi 経口抗炎症剤
US20020049422A1 (en) * 1994-03-31 2002-04-25 Brewitt Barbara A. Homeopathic preparations
WO2000056344A1 (fr) * 1999-03-24 2000-09-28 Seikagaku Corporation Salive artificielle
US7354910B2 (en) * 2001-10-18 2008-04-08 Seikagaku Kogyo Kabushiki Kaisha Agent for treating inflammatory bowel diseases
WO2005054204A2 (en) * 2003-11-26 2005-06-16 Synchrony Biosciences, Inc. Pharmaceutical compounds that regenerate in vivo
US20050143343A1 (en) * 2003-12-30 2005-06-30 Nerenberg Arnold P. Nutritional supplement for enhancing the production and effect of natural human growth hormone
ITMI20061932A1 (it) * 2006-10-09 2008-04-10 Carlo Ghisalberti Complessi a trasferimento di carica per uso medicale
JP5198899B2 (ja) * 2008-02-28 2013-05-15 株式会社コーセー 細胞賦活剤及び老化防止用皮膚外用剤
JP2009155337A (ja) * 2009-03-31 2009-07-16 Tsujido Chemical Corp 治療剤

Also Published As

Publication number Publication date
RS53598B1 (en) 2015-02-27
HRP20141099T1 (hr) 2014-12-19
BR112013013351A2 (pt) 2016-09-13
PT2646036E (pt) 2014-11-03
CA2819307A1 (en) 2012-06-07
AU2011336166B2 (en) 2016-03-24
AU2011336166A1 (en) 2013-06-20
WO2012073191A1 (en) 2012-06-07
HK1185008A1 (zh) 2014-02-07
DK2646036T3 (da) 2014-10-06
JP5847833B2 (ja) 2016-01-27
KR20140020838A (ko) 2014-02-19
ITMI20102218A1 (it) 2012-05-31
US9050351B2 (en) 2015-06-09
KR101845472B1 (ko) 2018-04-04
EP2646036B1 (en) 2014-08-27
ZA201303910B (en) 2014-07-30
PL2646036T3 (pl) 2015-02-27
MX337437B (es) 2016-03-03
IT1402907B1 (it) 2013-09-27
IL226638A (en) 2016-08-31
CN103313716A (zh) 2013-09-18
JP2014501733A (ja) 2014-01-23
SI2646036T1 (sl) 2014-12-31
RU2013125021A (ru) 2014-12-10
MX2013006045A (es) 2013-10-25
EP2646036A1 (en) 2013-10-09
BR112013013351B1 (pt) 2019-09-03
ES2521065T3 (es) 2014-11-12
US20120135087A1 (en) 2012-05-31
CN103313716B (zh) 2016-06-01
CA2819307C (en) 2018-08-14

Similar Documents

Publication Publication Date Title
CY1115708T1 (el) Τοπικες συνθεσεις για τη διατηρηση ή την ανακτηση της ακεραιοτητας των βλεννογονων
CY1118680T1 (el) Φαρμακευτικη συνθεση
CY1121360T1 (el) Αναστολεις dna-pk
CY1119056T1 (el) Παραγωγα 2',4',-διφθορο-2'-μεθυλ υποκατεστημενου νουκλεοσιδιου ως αναστολεις αντιγραφης hcv rna
CY1117986T1 (el) Ενωσεις αρυλ- ή ετεροαρυλ-υποκατεστημενου βενζολιου
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
CY1117678T1 (el) Ενωσεις αναστολεων μεταλλοενζυμου
CY1120557T1 (el) Μορια δεσμευσης anti-pseudomonas psl και χρησεις αυτων
CY1121736T1 (el) Άλατα aramchol
CR20180057A (es) Nuevos compuestos biciclicos como inhibidores duales de atx/ca.
CR20150436A (es) Nuevos octahidro-pirrolo[3,4-c]-pirrol y -piridina-fenilo
CR20160419A (es) Nuevos compuestos biciclicos
UY34474A (es) Composiciones, forma de dosificación y métodos para tratar el virus de la hepatitis C.
EA201590534A1 (ru) Новые бициклические производные
EA201492223A1 (ru) Новые диазаспироциклоалканы и азаспироциклоалканы
CR20180072A (es) Nuevos compuestos biciclicos como inhibidores de atx
BR112012028540A2 (pt) composições e métodos para melhorar desempenho fisiológico e tempo de recuperação
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
CY1121515T1 (el) Μεθοδοι και συνθεσεις για την επουλωση πληγων
CY1122115T1 (el) Παραγωγα ν1-ακυλο-5-φθοροπυριμιδινονης
EA201490846A1 (ru) Новые производные арилхинолина
EA201590887A1 (ru) Композиция
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
CY1116168T1 (el) Συγκρυσταλλοι και αλατα αναστολεων toy ccr3